A leading provider of
innovative DNA Screening solutions
P16 Deletion LPH 009
Deletions of chromosome 9p21 are implicated in a wide variety of tumours including approximately 10% of paediatric ALL patients, though the incidence is higher in T-ALL. The region has been the subject of much study but deletion of the potential tumour suppressor gene P16 (CDKN2A) was found to take place in 90% of newly diagnosed cases of paediatric ALL showing cytogenetic deletions of 9p21 by FISH. The gene product inhibits the Cyclin Dependent Kinases important in controlling the cell cycle so disruptions of this process are likely to result in the proliferation of mutated cells.
P16 Deletion
Cat. No. LPH 009-S (5 tests)
Cat. No. LPH 009 (10 tests)
- ALL
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK